BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21129645)

  • 1. [Recommendations Onco-Urology 2010: Urothelial tumors].
    Pfister C; Roupret M; Wallerand H; Davin JL; Quintens H; Guy L; Houede N; Bernardini S; Larré S; Mazerolles C; Roy C; Amsellem D; Saint F; Irani J; Soulié M;
    Prog Urol; 2010 Nov; 20 Suppl 4():S255-74. PubMed ID: 21129645
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of bladder tumors].
    Njinou B; Dardenne B; Darimont M; Wese FX; Van Cangh PJ
    Acta Urol Belg; 1999; 67(1):6-10. PubMed ID: 10859816
    [No Abstract]   [Full Text] [Related]  

  • 3. Current state of immunotherapy for bladder cancer.
    Kassouf W; Kamat AM
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):1037-46. PubMed ID: 15606331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of bacillus Calmette-Guerin refractory non-muscle invasive bladder cancer.
    Turker P; Turkeri L
    Arch Esp Urol; 2013 Nov; 66(9):833-40. PubMed ID: 24231293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bladder cancer and urothelial tumors. New therapeutic strategies].
    Desgrandchamps F; Hennequin C; Culine S
    Rev Prat; 2014 Dec; 64(10):1363-4. PubMed ID: 25665313
    [No Abstract]   [Full Text] [Related]  

  • 6. Bladder cancer: revealing news about a hidden threat.
    Campbell BD
    Nursing; 2006 Apr; 36(4):54-7. PubMed ID: 16582750
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant intravesical therapy based on an in vitro cytotoxicity assay in the management of superficial transitional cell cancer of the urinary bladder.
    Saxena S; Agrawal U; Agarwal A; Murthy NS; Mohanty NK
    BJU Int; 2006 Nov; 98(5):1012-7. PubMed ID: 17034604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [BCG therapy. Its role in the treatment of tumors of the bladder].
    Patard JJ; Chopin DK; Abbou CC
    Ann Urol (Paris); 1995; 29(5):292-3. PubMed ID: 8638911
    [No Abstract]   [Full Text] [Related]  

  • 9. [ BCG-immunotherapy and bladder cancer].
    Rischmann P
    Prog Urol; 2008 May; 18 Suppl 5():S93. PubMed ID: 18585633
    [No Abstract]   [Full Text] [Related]  

  • 10. Urothelial carcinoma.
    Merseburger AS; Shariat SF
    World J Urol; 2011 Aug; 29(4):405-7. PubMed ID: 21779833
    [No Abstract]   [Full Text] [Related]  

  • 11. [New concepts in management of NMIBC in 2010].
    Pignot G; Irani J; Bastide C; Ravery V
    Prog Urol; 2011 Mar; 21 Suppl 2():S34-7. PubMed ID: 21397825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon alfa in the treatment paradigm for non-muscle-invasive bladder cancer.
    Lamm D; Brausi M; O'Donnell MA; Witjes JA
    Urol Oncol; 2014 Jan; 32(1):35.e21-30. PubMed ID: 23628309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of treatment selection among surgeons for patients with cT1 urothelial carcinoma.
    Dalbagni G; Kaag M; Cronin A; Vora K; Bochner B; Donat SM; Herr HW
    BJU Int; 2010 Nov; 106(10):1502-7. PubMed ID: 20367633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aetiology, diagnosis and management of urothelial tumours of the renal pelvis and ureter.
    Maddineni SB; Clarke NW; Sutherland DE; Jarrett TW
    BJU Int; 2008 Nov; 102(9 Pt B):1302-6. PubMed ID: 19035896
    [No Abstract]   [Full Text] [Related]  

  • 16. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
    Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
    Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urothelial cancer of the urinary bladder: can lessons learned be applied to the upper urinary tract?
    Krabbe LM; Hutchinson RC; Margulis V
    Minerva Urol Nefrol; 2016 Aug; 68(4):396-408. PubMed ID: 26990295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment and follow-up of superficial bladder cancer].
    Raitanen M
    Duodecim; 2002; 118(9):903-9. PubMed ID: 12238168
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of BCG "Failures".
    Palou Redorta J
    Eur Urol; 2006 May; 49(5):779-80. PubMed ID: 16616207
    [No Abstract]   [Full Text] [Related]  

  • 20. Bladder cancer: current optimal intravesical treatment.
    Lamm DL; McGee WR; Hale K
    Urol Nurs; 2005 Oct; 25(5):323-6, 331-2. PubMed ID: 16294610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.